Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 278

1.

Plasma ADAMTS13 levels and the risk of myocardial infarction: an individual patient data meta-analysis.

Maino A, Siegerink B, Lotta LA, Crawley JT, le Cessie S, Leebeek FW, Lane DA, Lowe GD, Peyvandi F, Rosendaal FR.

J Thromb Haemost. 2015 Jun 15. doi: 10.1111/jth.13032. [Epub ahead of print]

PMID:
26073931
2.

Introduction and overview.

Mannucci PM, Peyvandi F.

Blood Rev. 2015 Jun;29 Suppl 1:S1-3. doi: 10.1016/S0268-960X(15)30001-1. No abstract available.

PMID:
26073364
3.

Hepatic fibrinogen storage disease: identification of two novel mutations (p.Asp316Asn, fibrinogen Pisa and p.Gly366Ser, fibrinogen Beograd) impacting on fibrinogen γ-module.

Asselta R, Robusto M, Braidotti P, Peyvandi F, Nastasio S, D'Antiga L, Perisic VN, Maggiore G, Caccia S, Duga S.

J Thromb Haemost. 2015 Jun 3. doi: 10.1111/jth.13021. [Epub ahead of print]

PMID:
26039544
4.

Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation.

Asselta R, Robusto M, Platé M, Santoro C, Peyvandi F, Duga S.

Thromb Res. 2015 Jul;136(1):168-74. doi: 10.1016/j.thromres.2015.05.007. Epub 2015 May 14.

PMID:
26006300
5.

Long-term prophylaxis in severe factor VII deficiency.

Siboni SM, Biguzzi E, Mistretta C, Garagiola I, Peyvandi F.

Haemophilia. 2015 May 8. doi: 10.1111/hae.12702. [Epub ahead of print]

PMID:
25952977
6.

Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia.

Rossio R, Franchi C, Ardoino I, Djade CD, Tettamanti M, Pasina L, Salerno F, Marengoni A, Corrao S, Marcucci M, Peyvandi F, Biganzoli EM, Nobili A, Mannucci PM; REPOSI Investigators.

Eur J Intern Med. 2015 Jun;26(5):330-7. doi: 10.1016/j.ejim.2015.04.002. Epub 2015 Apr 18.

PMID:
25898778
7.

How the direct oral anticoagulant apixaban affects thrombin generation parameters.

Tripodi A, Padovan L, Veena C, Scalambrino E, Testa S, Peyvandi F.

Thromb Res. 2015 Jun;135(6):1186-90. doi: 10.1016/j.thromres.2015.03.032. Epub 2015 Apr 9.

PMID:
25895845
8.

Mediterranean spotted fever and hearing impairment: a rare complication.

Rossio R, Conalbi V, Castagna V, Recalcati S, Torri A, Coen M, Cassulini LR, Peyvandi F.

Int J Infect Dis. 2015 Apr 16;35:34-36. doi: 10.1016/j.ijid.2015.04.005. [Epub ahead of print]

9.

Procoagulatory state in inflammatory bowel diseases is promoted by impaired intestinal barrier function.

Pastorelli L, Dozio E, Pisani LF, Boscolo-Anzoletti M, Vianello E, Munizio N, Spina L, Tontini GE, Peyvandi F, Corsi Romanelli MM, Vecchi M.

Gastroenterol Res Pract. 2015;2015:189341. doi: 10.1155/2015/189341. Epub 2015 Feb 12.

10.

Design of clinical trials for new products in hemophilia: communication from the SSC of the ISTH.

Dimichele DM, Lacroix-Desmazes S, Peyvandi F, Srivastava A, Rosendaal FR; Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders.

J Thromb Haemost. 2015 May;13(5):876-9. doi: 10.1111/jth.12882. Epub 2015 Apr 13. No abstract available.

PMID:
25728341
11.

Rare bleeding disorders: diagnosis and treatment.

Palla R, Peyvandi F, Shapiro AD.

Blood. 2015 Mar 26;125(13):2052-61. doi: 10.1182/blood-2014-08-532820. Epub 2015 Feb 23. Review.

PMID:
25712993
12.

Treatment of Hemophilia in the Near Future.

Peyvandi F, Garagiola I.

Semin Thromb Hemost. 2015 Feb 19. [Epub ahead of print]

PMID:
25703518
13.

Back pain: An old cause in a young adult.

Ferrari B, Rossio R, Peyvandi F.

Eur J Intern Med. 2015 Feb 17. pii: S0953-6205(15)00037-0. doi: 10.1016/j.ejim.2015.02.002. [Epub ahead of print] No abstract available.

PMID:
25701237
14.

Inhibitor development in haemophilia according to concentrate. Four-year results from the European HAemophilia Safety Surveillance (EUHASS) project.

Fischer K, Lassila R, Peyvandi F, Calizzani G, Gatt A, Lambert T, Windyga J, Iorio A, Gilman E, Makris M; EUHASS participants.

Thromb Haemost. 2015 Apr 29;113(5):968-75. doi: 10.1160/TH14-10-0826. Epub 2015 Jan 8.

PMID:
25567324
15.

Research in haemophilia B--approaching the request for high evidence levels in a rare disease.

Berger K, Schopohl D, Hilger A, Behr Gross ME, Giangrande P, Peyvandi F, Seitz R, Schramm W.

Haemophilia. 2015 Jan;21(1):4-20. doi: 10.1111/hae.12603. Epub 2014 Dec 11.

PMID:
25495927
16.

Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case-control study.

Ferrari B, Maino A, Lotta LA, Artoni A, Pontiggia S, Trisolini SM, Malato A, Rosendaal FR, Peyvandi F.

Orphanet J Rare Dis. 2014 Nov 28;9:193. doi: 10.1186/s13023-014-0193-6.

17.

Management of pregnancy in type 2B von Willebrand disease: case report and literature review.

Biguzzi E, Siboni SM, Ossola MW, Zaina B, Migliorini AC, Peyvandi F.

Haemophilia. 2015 Jan;21(1):e98-103. doi: 10.1111/hae.12580. Epub 2014 Nov 27. No abstract available.

PMID:
25431025
18.

Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency.

Asselta R, Platè M, Robusto M, Borhany M, Guella I, Soldà G, Afrasiabi A, Menegatti M, Shamsi T, Peyvandi F, Duga S.

Thromb Haemost. 2015 Mar;113(3):567-76. doi: 10.1160/TH14-07-0629. Epub 2014 Nov 27.

PMID:
25427968
19.

Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels.

Bucciarelli P, Siboni SM, Stufano F, Biguzzi E, Canciani MT, Baronciani L, Pagliari MT, La Marca S, Mistretta C, Rosendaal FR, Peyvandi F.

J Thromb Haemost. 2015 Feb;13(2):228-36. doi: 10.1111/jth.12799. Epub 2015 Jan 9.

PMID:
25425019
20.

A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity.

Rossio R, Lotta LA, Pontiggia S, Borsa NG, Garagiola I, Ardissino G, Mikovic D, Cugno M, Peyvandi F.

Haematologica. 2015 Mar;100(3):e87-9. doi: 10.3324/haematol.2014.111062. Epub 2014 Nov 7. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk